Literature DB >> 26024927

Feeding-induced oleoylethanolamide mobilization is disrupted in the gut of diet-induced obese rodents.

Miki Igarashi1, Nicholas V DiPatrizio1, Vidya Narayanaswami1, Daniele Piomelli2.   

Abstract

The gastrointestinal tract plays a critical role in the regulation of energy homeostasis by initiating neural and hormonal responses to the ingestion of nutrients. In addition to peptide hormones, such as cholecystokinin (CKK) and peptide YY (PYY), the lipid-derived mediator oleoylethanolamide (OEA) has been implicated in the control of satiety. Previous studies in humans and rodent models have shown that obesity is associated with changes in CCK, PYY and other gut-derived peptide hormones, which may contribute to decreased satiety and increased energy intake. In the present study, we show that small-intestinal OEA production is disrupted in the gut of diet-induced obese (DIO) rats and mice. In lean rodents, feeding or duodenal infusion of Intralipid® or pure oleic acid stimulates jejunal OEA mobilization. This response is strikingly absent in DIO rats and mice. Confirming previous reports, we found that feeding rats or mice a high-fat diet for 7 days is sufficient to suppress jejunal OEA mobilization. Surprisingly, a similar effect is elicited by feeding rats and mice a high-sucrose low-fat diet for 7 days. Collectively, our findings suggest that high fat-induced obesity is accompanied by alterations in the post-digestive machinery responsible for OEA biosynthesis, which may contribute to reduced satiety and hyperphagia.
Copyright © 2015 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Diet-induced obesity; Dietary fat; Linoleoylethanolamide; Oleoylethanolamide; Satiety

Mesh:

Substances:

Year:  2015        PMID: 26024927      PMCID: PMC4516666          DOI: 10.1016/j.bbalip.2015.05.006

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  46 in total

1.  A gut lipid messenger links excess dietary fat to dopamine deficiency.

Authors:  Luis A Tellez; Sara Medina; Wenfei Han; Jozelia G Ferreira; Paula Licona-Limón; Xueying Ren; Tukiet T Lam; Gary J Schwartz; Ivan E de Araujo
Journal:  Science       Date:  2013-08-16       Impact factor: 47.728

2.  Reduced CCK signaling in obese-prone rats fed a high fat diet.

Authors:  Frank A Duca; Li Zhong; Mihai Covasa
Journal:  Horm Behav       Date:  2013-10-05       Impact factor: 3.587

Review 3.  Nutrient sensing in the gut: new roads to therapeutics?

Authors:  Sara Janssen; Inge Depoortere
Journal:  Trends Endocrinol Metab       Date:  2012-12-21       Impact factor: 12.015

Review 4.  Overeating makes the gut grow fonder; new insights in gastrointestinal satiety signaling in obesity.

Authors:  Jeroen Maljaars
Journal:  Curr Opin Gastroenterol       Date:  2013-03       Impact factor: 3.287

Review 5.  Lipidomic analysis of endocannabinoid metabolism in biological samples.

Authors:  Giuseppe Astarita; Daniele Piomelli
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2009-01-14       Impact factor: 3.205

6.  The lipid messenger OEA links dietary fat intake to satiety.

Authors:  Jin Fu; Giuseppe Astarita; Gary J Schwartz; Xiaosong Li; Silvana Gaetani; Patrizia Campolongo; Vincenzo Cuomo; Daniele Piomelli
Journal:  Cell Metab       Date:  2008-10       Impact factor: 27.287

Review 7.  Biosynthetic pathways of bioactive N-acylethanolamines in brain.

Authors:  Kazuhito Tsuboi; Natsuki Ikematsu; Toru Uyama; Dale G Deutsch; Akira Tokumura; Natsuo Ueda
Journal:  CNS Neurol Disord Drug Targets       Date:  2013-02-01       Impact factor: 4.388

Review 8.  A fatty gut feeling.

Authors:  Daniele Piomelli
Journal:  Trends Endocrinol Metab       Date:  2013-04-06       Impact factor: 12.015

Review 9.  Origin and physiological roles of inflammation.

Authors:  Ruslan Medzhitov
Journal:  Nature       Date:  2008-07-24       Impact factor: 49.962

10.  Dietary non-esterified oleic Acid decreases the jejunal levels of anorectic N-acylethanolamines.

Authors:  Thi Ai Diep; Andreas N Madsen; Sandra Krogh-Hansen; Marwa Al-Shahwani; Laila Al-Sabagh; Birgitte Holst; Harald S Hansen
Journal:  PLoS One       Date:  2014-06-24       Impact factor: 3.240

View more
  18 in total

Review 1.  CRISPR/Cas9, the Powerful New Genome-Editing Tool for Putative Therapeutics in Obesity.

Authors:  María José Franco-Tormo; Mireille Salas-Crisostomo; Nuno Barbosa Rocha; Henning Budde; Sérgio Machado; Eric Murillo-Rodríguez
Journal:  J Mol Neurosci       Date:  2018-05-07       Impact factor: 3.444

Review 2.  Obesity: Current and potential pharmacotherapeutics and targets.

Authors:  Vidya Narayanaswami; Linda P Dwoskin
Journal:  Pharmacol Ther       Date:  2016-10-20       Impact factor: 12.310

3.  Dysfunctional oleoylethanolamide signaling in a mouse model of Prader-Willi syndrome.

Authors:  Miki Igarashi; Vidya Narayanaswami; Virginia Kimonis; Pietro M Galassetti; Fariba Oveisi; Kwang-Mook Jung; Daniele Piomelli
Journal:  Pharmacol Res       Date:  2016-12-19       Impact factor: 7.658

4.  Two-week administration of engineered Escherichia coli establishes persistent resistance to diet-induced obesity even without antibiotic pre-treatment.

Authors:  Noura S Dosoky; Zhongyi Chen; Yan Guo; Clara McMillan; C Robb Flynn; Sean S Davies
Journal:  Appl Microbiol Biotechnol       Date:  2019-06-15       Impact factor: 4.813

5.  Leptogenic effects of NAPE require activity of NAPE-hydrolyzing phospholipase D.

Authors:  Zhongyi Chen; Yongqin Zhang; Lilu Guo; Noura Dosoky; Lorenzo de Ferra; Scott Peters; Kevin D Niswender; Sean S Davies
Journal:  J Lipid Res       Date:  2017-06-08       Impact factor: 5.922

Review 6.  The Expanded Endocannabinoid System/Endocannabinoidome as a Potential Target for Treating Diabetes Mellitus.

Authors:  Alain Veilleux; Vincenzo Di Marzo; Cristoforo Silvestri
Journal:  Curr Diab Rep       Date:  2019-11-04       Impact factor: 4.810

Review 7.  A Duet Between Histamine and Oleoylethanolamide in the Control of Homeostatic and Cognitive Processes.

Authors:  Gustavo Provensi; Alessia Costa; Barbara Rani; Patrizio Blandina; M Beatrice Passani
Journal:  Curr Top Behav Neurosci       Date:  2022

8.  Association between plasma endocannabinoids and appetite in hemodialysis patients: A pilot study.

Authors:  Allon N Friedman; Jeffrey Kim; Shaun Kaiser; Theresa L Pedersen; John W Newman; Bruce A Watkins
Journal:  Nutr Res       Date:  2016-04-01       Impact factor: 3.315

Review 9.  Endocannabinoids--at the crossroads between the gut microbiota and host metabolism.

Authors:  Patrice D Cani; Hubert Plovier; Matthias Van Hul; Lucie Geurts; Nathalie M Delzenne; Céline Druart; Amandine Everard
Journal:  Nat Rev Endocrinol       Date:  2015-12-18       Impact factor: 43.330

Review 10.  Non-endocannabinoid N-acylethanolamines and 2-monoacylglycerols in the intestine.

Authors:  Harald S Hansen; Vasiliki Vana
Journal:  Br J Pharmacol       Date:  2018-04-02       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.